Endometrial cancer and its cell lines

被引:20
|
作者
Skok, Kristijan [1 ,2 ]
Maver, Uros [1 ,3 ]
Gradisnik, Lidija [1 ]
Kozar, Nejc [4 ,5 ]
Takac, Iztok [4 ,5 ]
Arko, Darja [4 ,5 ]
机构
[1] Univ Maribor, Inst Biomed Sci, Fac Med, Taborska Ulica 8, SI-2000 Maribor, Slovenia
[2] Gen Hosp Graz II, Dept Pathol, Location West,Gostinger Str 22, A-8020 Graz, Austria
[3] Univ Maribor, Dept Pharmacol, Fac Med, Maribor, Slovenia
[4] Univ Maribor, Fac Med, Taborska Ulica 8, SLO-2000 Maribor, Slovenia
[5] Univ Med Ctr Maribor, Div Gynaecol & Perinatol, Ljubljanska 5, Maribor 2000, Slovenia
关键词
Endometrial cancer; Cell line; Tissue culture; Cancer cell line; In vitro models; Cell isolation; RESOURCE; ISHIKAWA; MODELS;
D O I
10.1007/s11033-019-05226-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endometrial cancer is one of the most common gynaecological malignancies worldwide. One type of research in this field is the growing of cell lines (CLs) and cultures, which can be used to explore the biological mechanisms of cancer. The purpose of this review is to offer an overview of the current literature and highlight the importance of correct CL studies. We carried out a literature analysis of more than 60 articles from the Pubmed, Medline databases that were almost exclusively published in indexed journals in the last 10 years as well as the primary originating scientific studies of specific CLs. We then summarized the newest findings and recommendations. Cell lines are becoming widely used as in vitro tumour models. Recent work has shown inconsistencies in nomenclature and culturing of CLs. Their genomic evolution leads to a high degree of variation across CL strains therefore it is of the utmost importance to recognize the variability within laboratory cancer models. Laboratories must adapt, incorporate additional characterisation techniques and view this situation as an opportunity to improve the reproducibility of pre-clinical cancer research. The authors offer a comprehensive literature review about endometrial cancer CLs, a review of the current literature and advice on culturing CLs.
引用
收藏
页码:1399 / 1411
页数:13
相关论文
共 50 条
  • [41] Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer
    Kim, Jisup
    Kim, Sinae
    Lee, Hye Sun
    Yang, Wookyeom
    Cho, Hanbyoul
    Chay, Doo Byung
    Cho, Seong Jin
    Hong, Soonwon
    Kim, Jae-Hoon
    GYNECOLOGIC ONCOLOGY, 2018, 149 (02) : 381 - 387
  • [42] Defining the extent of cables loss in endometrial cancer subtypes and its effectiveness as an inhibitor of cell proliferation in malignant endometrial cells in vitro and in vivo
    DeBernardo, RL
    Littell, RD
    Luo, HW
    Duska, LR
    Oliva, E
    Kirley, SD
    Lynch, MP
    Zukerberg, LR
    Rueda, BR
    CANCER BIOLOGY & THERAPY, 2005, 4 (01) : 103 - 107
  • [43] Hepsin inhibits the cell growth of endometrial cancer
    Nakamura, Keiichiro
    Takamoto, Norio
    Abarzua, Fernando
    Hongo, Atsushi
    Kodama, Junichi
    Nasu, Yasutomo
    Kumon, Hiromi
    Hiramatsu, Yuji
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2008, 22 (03) : 389 - 397
  • [44] Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors
    Philip, Charles-Andre
    Laskov, Ido
    Beauchamp, Marie-Claude
    Marques, Maud
    Amin, Oreekha
    Bitharas, Joanna
    Kessous, Roy
    Kogan, Liron
    Baloch, Tahira
    Gotlieb, Walter H.
    Yasmeen, Amber
    BMC CANCER, 2017, 17
  • [45] Invasiveness of endometrial cancer cell lines is potentiated by estradiol and blocked by a traditional medicine Guizhi Fuling at clinically relevant doses
    Khan, Sidra
    Varricchio, Alanah
    Ricciardelli, Carmela
    Yool, Andrea J.
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [46] Exposure to select PFAS and PFAS mixtures alters response to platinum-based chemotherapy in endometrial cancer cell lines
    Rickard, Brittany P.
    Overchuk, Marta
    Tulino, Justin
    Tan, Xianming
    Ligler, Frances S.
    Bae-Jump, Victoria L.
    Fenton, Suzanne E.
    Rizvi, Imran
    ENVIRONMENTAL HEALTH, 2023, 22 (01)
  • [47] Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors
    Charles-André Philip
    Ido Laskov
    Marie-Claude Beauchamp
    Maud Marques
    Oreekha Amin
    Joanna Bitharas
    Roy Kessous
    Liron Kogan
    Tahira Baloch
    Walter H. Gotlieb
    Amber Yasmeen
    BMC Cancer, 17
  • [48] Exposure to select PFAS and PFAS mixtures alters response to platinum-based chemotherapy in endometrial cancer cell lines
    Brittany P. Rickard
    Marta Overchuk
    Justin Tulino
    Xianming Tan
    Frances S. Ligler
    Victoria L. Bae-Jump
    Suzanne E. Fenton
    Imran Rizvi
    Environmental Health, 22
  • [49] Differences in invasive capacity of endometrial cancer cell lines expressing different progesterone receptor isotypes: Possible involvement of cadherins
    Hanekamp, EE
    Gielen, SCJP
    De Ruiter, PE
    Chadha-Ajwani, S
    Huikeshoven, FJ
    Burger, CW
    Grootegoed, JA
    Blok, LJ
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2005, 12 (04) : 278 - 284
  • [50] Differences in Invasive Capacity of Endometrial Cancer Cell Lines Expressing Different Progesterone Receptor Isotypes: Possible Involvement of Cadherins
    Eline E. Hanekamp
    Susanne C. J. P. Gielen
    Petra E. De Ruiter
    Savi Chadha-Ajwani
    Frans J. Huikeshoven
    Curt W. Burger
    J. Anton Grootegoed
    Leen J. Blok
    The Journal of the Society for Gynecologic Investigation: JSGI, 2005, 12 : 278 - 284